2014 Keynotes and Session Chairs
Tim Wells, PhD
Tim is the Chief Scientific Officer at Medicines for Malaria Venture (MMV), a not-for-profit public-private partnership whose mission is to reduce the burden of malaria in disease-endemic countries by discovering, developing and facilitating delivery of new, effective and affordable antimalarial drugs. As the Chief Scientific Officer, Tim is responsible for the overall direction of MMV’s portfolio of projects. He brings to MMV leadership and expertise in product development, research strategy, management of research alliances and multiple therapeutic areas from infectious disease, through inflammation to neurology and reproductive health. Tim is a Fellow of the Royal Society of Chemistry and the UK Academy of Medical Sciences and previously served as Senior Executive Vice President Research at Serono and ran Protein Biochemistry at Glaxo Institute for Molecular Biology.
Title: The pipeline of medicines to support malaria control and elimination
Keynote Highlight Address
Joseph DeRisi, PhD
Joe is a Professor and Vice Chair of the Department of Biochemistry and Biophysics at the University of California, San Francisco, and a Howard Hughes Medical Institute Investigator. He employs an interdisciplinary approach to his work, combining genomics, bioinformatics, biochemistry, and bioengineering to study parasitic and viral infectious diseases in a wide range of organisms. Joe was one of the early pioneers of DNA microarray technology and whole genome expression profiling and is nationally recognized for his efforts to make this technology accessible and freely available. Today, he uses this approach to study the activity of the full range of malaria genes and has generated provocative insights in many emerging viral diseases.
Title: A view from the trenches – Anti-malarial drug development
Closing Keynote Address
Regina Rabinovich, MD, MPH
Regina is the ExxonMobil Malaria Scholar in Residence at Harvard University, and Visiting Scholar at ISGLOBAL at the University of Barcelona, working on malaria governance and malaria elimination. She has over 25 years of experience in global health across research, public health, and philanthropic sectors, with focus on strategy, global health product development, and the introduction and scale-up of tools and strategies resulting in impact on endemic populations. For the prior decade, she served as Director of the Infectious Diseases division at the Bill & Melinda Gates Foundation, overseeing the programs for malaria, pneumonia, diarrhea, and neglected infectious diseases. Regina was founding director of the PATH Malaria Vaccine Initiative, and was Chief of the Clinical and Regulatory Affairs Branch at the US NIAID. She serves on the boards of AERAS, a non-profit TB vaccine biotech, the Catholic Medical Mission Board, serves as technical reviewer for UNITAID, and advisor to the Malaria Eradication Scientific Alliance. Regina holds a medical degree from Southern Illinois University and a Masters of Public Health degree from the University of North Carolina.
Title: Beyond the Millennium Development Goals horizon – What will help drive success post-2015?
Research and Exploration Session Chair
Peter Zimmerman, PhD – Pete is a Professor in the Center for Global Health & Diseases, at Case Western Reserve University, in Cleveland, Ohio. He has conducted population-based research on many aspects of malaria in Papua New Guinea and Madagascar. Much of this work has focused on Plasmodium vivax, a persistent parasite that will require special attention as malaria elimination efforts move forward. Pete’s prior research experience included a postdoctoral fellowship in the Laboratory of Parasitic Diseases and he received his PhD degree from CWRU.
Title: The evolving challenge of vivax malaria
Technical Innovation Session Chair
Aydogan Ozcan, PhD – Aydogan is the Chancellor’s Professor at UCLA leading the Bio- and Nano-Photonics Laboratory at the Electrical Engineering and Bioengineering Departments. He holds 22 issued patents (all of which are licensed) and >15 pending patent applications and is also the author of one book and the co-author of more than 350 peer reviewed research articles in major scientific journals and conferences. Aydogan is a Fellow of SPIE and OSA, and has received major awards including the Presidential Early Career Award for Scientists and Engineers (PECASE), SPIE Biophotonics Technology Innovator Award, SPIE Early Career Achievement Award, ARO Young Investigator Award, NSF CAREER Award, NIH Director’s New Innovator Award, ONR Young Investigator Award, IEEE Photonics Society Young Investigator Award and MIT’s TR35 Award for his seminal contributions to near-field and on-chip imaging, and telemedicine based diagnostics. He is also the recipient of the National Geographic Emerging Explorer Award, National Academy of Engineering (NAE) The Grainger Foundation Frontiers of Engineering Award, Popular Science Brilliant 10 Award, Gates Foundation Grand Challenges Award, Popular Mechanics Breakthrough Award, Netexplorateur Award, Microscopy Today Innovation Award, and the Wireless Innovation Award organized by the Vodafone Americas Foundation as well as the Okawa Foundation Award. http://innovate.ee.ucla.edu/ http://org.ee.ucla.edu/
Title: BioGames: Crowd-Sourced Games for Malaria Diagnosis and Telepathology
Implementation of Campaigns, Programs and Policy Session Chair
Elizabeth Ponder, PhD – Elizabeth is the Executive Director of the Henry Wheeler Center for Emerging & Neglected Diseases (CEND) at the University of California Berkeley. The mission of CEND is to help the University of California, Berkeley make innovative and substantial contributions to the global response to emerging and neglected infectious diseases. Prior to joining CEND, Elizabeth served as the Associate Director of Scientific Affairs at the non-profit organization BIO Ventures for Global Health (BVGH). Her work at BVGH focused on facilitating and promoting public-private partnerships, particularly with the biotech sector, to advance drug, vaccine, and diagnostic development for neglected infectious diseases. Elizabeth completed her PhD and a short postdoctoral fellowship at Stanford University in the laboratory of Dr. Matthew Bogyo. Her work focused on understanding the biological function and drug target potential of proteases of Plasmodium falciparum. As part of her transition from training in laboratory research to a career global health, Elizabeth traveled to Garissa, Kenya to conduct research on the rollout of rapid diagnostic tests for improved management of malaria with the non-profit organization the MENTOR Initiative.
Title: Feedback from the Field: Implementation as a Driver of New Innovation